Interleukin-35 (IL-35) is implicated in tumorigenesis, but its exact impact on intrahepatic cholangiocarcinoma (ICC) is not clear. The aim of the present study was to explore the specific effect of IL-35 on patient prognosis. Additionally, we formulated an effective prognostic nomogram for ICC patients after curative resection. 
Interleukin-35 (IL-35) is implicated in tumorigenesis, but its exact impact on intrahepatic cholangiocarcinoma (ICC) is not clear. The aim of the present study was to explore the specific effect of IL-35 on patient prognosis. Additionally, we formulated an effective prognostic nomogram for ICC patients after curative resection.
Immunohistochemistry was applied to explore IL-35 expression as well as receptor (IL-35R) in 102 ICC patients. Results showed that IL-35 was highly expressed in ICC tumor tissues and was positively associated with lymph node metastasis (LNM), TNM stage and vascular invasion and was an independent prognostic factor for patients' overall survival (OS) and recurrence-free survival (RFS).
High expression of IL-35R (gp130 and IL-12Rb2) was also observed in ICC cancer
tissues, but only gp130 was an independent prognostic factor for OS and RFS and 
| INTRODUCTION
Intrahepatic cholangiocarcinoma is the second most common liver malignancy arising from the intrahepatic biliary tract, 1 and accounts for 10% to 15% of primary liver cancer. 2 As an uncommon disease, in recent years, the incidence of ICC is drastically increasing worldwide, 3 but there is hardly any progress in the treatment of ICC for OS rate which is still around 22%-40% after surgical resection. 4, 5 To make matters worse, such a dismal situation manifests a major challenge as most ICC patients are not sensitive to conventional chemotherapy and radiotherapy. 6, 7 In addition, early identification of ICC seems more difficult because of the early lymphatic metastasis and limited effective diagnoses. 8 Therefore, new and specific prognostic biomarkers or scoring systems to stratify the prognosis in ICC patients are urgently needed.
In recent years, much research has confirmed that the tumor microenvironment serves an important role in tumor development. 9 Tumor cells use multiple mechanisms to establish an immunosuppressive network for dampening antitumor immunity, predominately by the production of inhibitory immune molecules and induction of regulatory cells. 10 24 The interval between surgery and death was defined as OS and the interval between surgery and time of recurrence was defined as RFS.
| Tissue microarray construction and immunohistochemistry
Tissue microarrays were constructed according to a previous research report. 25 Two different tissue microarray blocks extracted from each case (3-mm-diameter each) were used for TMA construction.
Monoclonal rabbit antihuman antibodies P35, EBI3, gp130 and IL-12Rb2 (1:100 dilution) were purchased from Abcam (Cambridge, UK). IHC was used to detect the expression of P35, EBI3, gp130
and IL-12Rb2 in tissues of ICC, and surgical produces were carried out as described. 26 Two experienced observers were responsible for sliced evaluation in a double blind method. Expression of IL-35, EBI3
gp130 and IL-12Rb2 was evaluated by a semiquantitative scoring system. 27 The final score was made by positively stained tumor cells (0, no positive tumor cells; 1, <10%; 2, 10%-35%; 3, 35%-75%; 4, >75%) multiplied by staining intensity (1, no staining; 2, weak; 3, moderate; 4, strong). Eventually, total scores ≥8 were defined as high expression and those <8 were defined as low expression. Representative images of positive and negative controls for IHC are shown in Figure S1 .
| Cell lines and cell culture
Human cholangiocarcinoma cell lines RBE, HUCCT-1, HCCC9810
and normal bile duct cell HIBEpic (HBP) were obtained from the Chinese Academy of Sciences (Beijing, China). Cells were cultured in RPMI-1640 with 10% FBS and 1% penicillin-streptomycin (Hyclone, Logan, UT, USA), cultured in a 37°C incubator with 5% CO 2.
| Western blot
Protein (30 lg) was separated by 10% SDS-PAGE electrophoresis, then transferred to PVDF (Millipore, Temecula, CA, USA), and the membranes were blocked in 5% BSA for 1 hour, then incubated with primary antibodies (P35, EBI3, gp130 and IL-12Rb2 (1:1000 dilution; Abcam) at 4°C overnight. b-Actin (Kangcheng, Shanghai, China) was used as an internal control. After 12 hours, the membranes were incubated with secondary antibody (Kangcheng) for 1 hour at room temperature.
Finally, the protein bands were detected by enhanced chemiluminescent (ECL) substrate and processed by Image, Lab software (Bio-Rad, Mississauga, ON, Canada). 28 Predictive accuracy of the nomogram was measured by C-index and calibration curve. The larger the C-index, the more accurate the prognostic prediction. 29 DCA, a novel evaluation method, assessed the clinical usefulness of the nomograms for the prediction of prognosis. 30 This method used a different weight to the true-and false-positive results for incorporating the clinical outcomes of the nomogram. This weight was varied for reflecting divergence in patient preferences or differences in the risks of a procedure. These preferences were expressed in terms of a threshold probability. The following formula was used to calculate the net benefit of DCA.
| Statistical analysis
Netbenefit¼trueÀpositives=nÀfalseÀpositives=nÂðpt=ð1ÀptÞÞ , where n is total patients, and pt is threshold probability of OS. A high net benefit calculated with favorable probability was the optimal nomogram model. This method and the interpretation of final results are described in detail in these two studies.
30,31
3 | RESULTS
| Patient clinicopathological profiles
A total of 102 patients were included in the present study (64 males and 38 females) and average age of the patients was 61.4 AE 9.7 years.
Mean tumor size was (5.4 AE 2.7) cm, and 61 patients (59.9%) were noted with tumor size ≥5 cm. Twenty-three (22.6%) patients had (both EBI3 and P35 IHC scores were ≥8). To explore the correlation between IL-35 and ICC, we carried out IHC analysis of coexpression of P35 and EBI3 in both tumor tissues and matched paratumor specimens. P35 and EBI3 showed perfect colocalization and were primarily localized in the cytoplasm of ICC tissues. In addition, P35 and EBI3 expression was also identified in some nuclei ( Figure 1 ). Expression level of both P35 and EBI3 in tumor tissues was similar to paratumor tissues. P35 and EBI3 were rarely expressed in infiltrating lymphocytes and endothelial cells in ICC tissues ( Figures S2,S3 ). However, IL-12Rb2 was not an independent prognostic factor for both OS (P = .312, v 2 = 1.020) and RFS (P = .725, v 2 = .124) (Figure 3E,F) . (Table 2) . Additionally, multivariate analyses indicated that IL-35, gp130, LNM, and CEA were independent prognostic factors for OS, and that LNM was an independent prognostic factor for RFS (Table 3) . Regrettably, the signifi- 
| Prognostic nomogram for OS
Finally, we integrated all significant independent prognostic factors according to multivariate analysis (Table 3) CEA, carcinoembryonic antigen; 95% CI, 95% confidence interval; HR, hazard ratio; IL, interleukin; OS, overall survival, RFS, recurrence-free survival. The bold values were considered to be significant differences.
Herein, we detected expression of IL-35 in 102 ICC patients and conducted a series of prognostic analyses. We first used coexpression of two IL-35 subunits EBI3 and P35 to serve as a proxy to determine IL-35 level. As discovered, EBI3 and P35 were highly coexpressed in ICC tumor tissues, which was consistent with previous findings. [34] [35] [36] In line with the related research on pancreatic cancer, 19 CEA, carcinoembryonic antigen; 95% CI, 95% confidence interval; HR, hazard ratio; IL, interleukin; NA, not applicable; OS, overall survival, RFS, recurrence-free survival. The bold values were considered to be significant differences.
T A B L E 3 Multivariate analyses of factors associated with OS and RFS illustrated the poorest OS and shortest RFS, but no significant positive correlation was observed when IL-35 was combined with IL12Rb2, which was identical to a recent study. 19 This evidence was provocative in suggesting that although both subunits of IL-35R
were expressed in ICC, only gp130 was indispensable in IL-35-mediated ICC clinical prognosis.
Research has shown that nomograms can establish a more effective model in the prediction of prognosis of cancers compared with the traditional staging system, and the serological marker CEA has been viewed as independent risk factor for the prognosis of ICC. 28 It is therefore logical to create a nomogram integrating CEA, lymph node metastasis, IL-35 and gp130 expression to verify whether the predictive performance of a nomogram is better than traditional staging systems in ICC. Fortunately, our nomogram provided better predictive accuracy in the prediction of OS relative to TNM stage.
Our results were supportive in suggesting that immune molecules (IL-35, gp130) should be incorporated into the ICC prognostic system to improve discriminative ability.
Several limitations in the present study should be noted. First, the study was retrospective in nature and the patients were from a single institution in China. Second, as a result of the relatively small number of clinical patients included in this study, external validation was not carried out. Third, follow-up time was relatively short, as only 3 years of OS and RFS were included in our study.
In conclusion, despite the acknowledged limitations, our results suggest that high IL-35 level positively associates with ICC aggressiveness and can be viewed as a convenient novel prognostic factor for the prediction of survival and recurrence in ICC patients.
